Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089

BioSpace >

New publication: COATI: Multimodal Contrastive Pretraining for Representing and Traversing Chemical Space

Journal of Chemical Information and Modeling >

Elegen Partners with GSK

Synbio Beta >

Bonum was named as one of the “Top Bioscience Companies to Watch” by Biospace

BioSpace >

Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb

PR Newswire >

Sanofi-backed T-Therapeutics bags $59M in Series A to unlock potential of TCR therapeutics

Endpoints News >

Code Ocean Honored by the 2023 BioTech Breakthrough Awards

PR Web >

Faeth Therapeutics to Participate in the Stifel 2023 Healthcare Conference

Business Wire >

DNA writing technologies moving toward synthetic genomes

Nature Biotechnology >

Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee

Business Wire >

Eden Brew alternative milk startup attracts $25m in investments to bring synthetic dairy to market

ABC News >

Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer

Business Wire >

A New Molecular Language for Generative AI in Small-Molecule Drug Discovery

NVIDIA >

GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies

Business Wire >

EpiBiologics: Protein Degradation Platform Company Closes Over $70 Million

Pulse 2.0 >

Elemental Machines Announces Edward Seguine As New Chief Executive Officer

PR Newswire >

GRO Biosciences demonstrates how automated technologies enable its scientists to test wide spaces

Biotech TV >

The Next Generation of Bio Companies

Decoding Bio >

SeQure Dx to present at American Society of Gene and Cell Therapy (ASGCT) on the importance of incorporating population heterogeneity evaluation into gene editing and cell therapy off-target analyses

Business Wire >

Code Ocean Accelerates Pharmaceutical and Biotech Research

PR News Wire >

Can you take the cow out of milk without losing texture and flavour

Cosmos >

GRO Biosciences CEO, Daniel J. Mandell, PhD, Awarded 2023 Termeer Fellowship

Business Wire >

Switch Therapeutics Raises $52M in Series A Funding

FINSMES >

Code Ocean Partners with Nature Portfolio to Launch the Open Science Library with Ready-to-Run Software from Authors in Nature Journals

PR Newswire >

Paths to cheminformatics: Q&A with Phyo Phyo Kyaw Zin

Journal of Cheminformatics >

Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer

Business Wire >

Elemental Machines Is Bringing The Internet Of Things To Lab Operations To Save Millions Of Dollars For Biotech Companies

Forbes >

Terray Therapeutics Appoints John Maraganore, Ph.D., as Strategic Advisor

Bezinga >

Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

Finding Genius Podcast >

Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director

PRNewswire >

A recipe for cancer, new clinical trial comes to Birmingham

CBS42 >

SeQure Dx Emerges From Stealth Mode to Fulfill the Promise of On-Target Gene Editing Therapies for Biopharma Partners, Physicians, and Patients

BusinessWire >

The team that sold its lead IL-2 program to Roche is back with $93M to work on more next-gen I/O drugs

Endpoints >

Elemental Machines raises $41 million to fuel growth

PRNewswire >

Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases

BusinessWire >

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

EndPoints >

Precision nutrition is the fourth pillar in cancer care, says Faeth Therapeutics

Vitafoods Insight >

‘Food-as-Medicine’ Startups Draw Venture Capital

WSJ

AI Is Making Its Way Into Drug Discovery. What Does It Mean For Biotech?

CrunchBase >

Future of Precision Health w/ Carlos Bustamante - Professor @ Stanford / Co-Founder & CEO @ Galatea - BIOS

SPOTIFY >

Faeth Therapeutics offers food for thought in the fight against cancer

The Times >

Good Therapeutics announced it has entered into a definitive merger agreement to be acquired by Roche for its lead asset. The broader technology will continue its development through new company named Bonum Therapeutics.

Business Wire >

How Microbial Fermentation Is Taking Eleven Madison Park’s Vegan Menu to the Next Level

VegNews >

Code Ocean Announces Open Science Library Allowing No-cost, Turn-key Replication of Computational Science Experiments

PR Newswire >

Elemental Machines Introduces Lab-Wide Equipment Usage Intel Solution

lab manager >

Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery

PR Newswire >

Faeth Therapeutics raises $47 million to advance clinical trials and feed the fight against cancer

PR NewsWire >

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Endpoints News >